Held by 2 specialist biotech funds
**Signal Note: Eventide/RMBS Position Initiation** This position initiation appears misaligned with Eventide's biotech-focused mandate, as Rambus is a semiconductor IP and memory interface company with no pharmaceutical operations. The $949K position may represent a values-based portfolio diversification move or a data analytics error in reporting, rather than a biotech catalyst-driven entry.